These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31935222)

  • 21. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
    Hwang M; Bergmann CC
    J Virol; 2018 May; 92(10):. PubMed ID: 29491163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of interferon α and β receptor IFNAR1 and IFNAR2 expression and regulation in the uterine endometrium during the estrous cycle and pregnancy in pigs.
    Jang H; Choi Y; Yoo I; Han J; Kim M; Ka H
    Theriogenology; 2017 Jan; 88():166-173. PubMed ID: 27769575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.
    Hardy MP; Owczarek CM; Trajanovska S; Liu X; Kola I; Hertzog PJ
    Blood; 2001 Jan; 97(2):473-82. PubMed ID: 11154225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.
    Fricke-Galindo I; Martínez-Morales A; Chávez-Galán L; Ocaña-Guzmán R; Buendía-Roldán I; Pérez-Rubio G; Hernández-Zenteno RJ; Verónica-Aguilar A; Alarcón-Dionet A; Aguilar-Duran H; Gutiérrez-Pérez IA; Zaragoza-García O; Alanis-Ponce J; Camarena A; Bautista-Becerril B; Nava-Quiroz KJ; Mejía M; Guzmán-Guzmán IP; Falfán-Valencia R
    Front Immunol; 2022; 13():949413. PubMed ID: 35967349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs.
    Cheng L; Ma J; Li J; Li D; Li G; Li F; Zhang Q; Yu H; Yasui F; Ye C; Tsao LC; Hu Z; Su L; Zhang L
    J Clin Invest; 2017 Jan; 127(1):269-279. PubMed ID: 27941247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon α subtypes in HIV infection.
    Sutter K; Dickow J; Dittmer U
    Cytokine Growth Factor Rev; 2018 Apr; 40():13-18. PubMed ID: 29475588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
    Piehler J; Schreiber G
    J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.
    Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B
    J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief Report: Increased Expression of the Type I Interferon Receptor on CD4+ T Lymphocytes in HIV-1-Infected Individuals.
    Killian MS; Fujimura SH; Sudhagoni RG
    J Acquir Immune Defic Syndr; 2017 Apr; 74(4):473-478. PubMed ID: 28009639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice.
    Skelton JK; Ortega-Prieto AM; Kaye S; Jimenez-Guardeño JM; Turner J; Malim MH; Towers GJ; Dorner M
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection.
    Dionne KR; Galvin JM; Schittone SA; Clarke P; Tyler KL
    J Neurovirol; 2011 Aug; 17(4):314-26. PubMed ID: 21671121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFNα Subtypes in HIV Infection and Immunity.
    Karakoese Z; Ingola M; Sitek B; Dittmer U; Sutter K
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I interferon responses are impaired in latently HIV infected cells.
    Ranganath N; Sandstrom TS; Fadel S; Côté SC; Angel JB
    Retrovirology; 2016 Sep; 13(1):66. PubMed ID: 27613235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling.
    Nguyen VP; Saleh AZ; Arch AE; Yan H; Piazza F; Kim J; Krolewski JJ
    J Biol Chem; 2002 Mar; 277(12):9713-21. PubMed ID: 11786546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human IFNAR2 Mutant Generated by CRISPR/Cas9-Induced Exon Skipping Upregulates a Subset of Tonic-Like Interferon-Stimulated Genes Upon IFNβ Stimulation.
    Zhang L; Ma J; Jin X; Zhang L; Zhang M; Li PZ; Li J; Zhang L
    J Interferon Cytokine Res; 2022 Nov; 42(11):580-589. PubMed ID: 36346319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased type I interferon receptor-soluble isoform in antiretroviral-treated HIV-positive children.
    Sottini A; Ghidini C; Serana F; Chiarini M; Valotti M; Badolato R; Radeghieri A; Caimi L; Imberti L
    J Interferon Cytokine Res; 2008 Mar; 28(3):181-9. PubMed ID: 18338950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs.
    Shemesh M; Lochte S; Piehler J; Schreiber G
    Sci Signal; 2021 Nov; 14(710):eabe4627. PubMed ID: 34813358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function of type I and III interferons.
    de Weerd NA; Kurowska AK; Mendoza JL; Schreiber G
    Curr Opin Immunol; 2024 Feb; 86():102413. PubMed ID: 38608537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome.
    Malle L; Martin-Fernandez M; Buta S; Richardson A; Bush D; Bogunovic D
    Immunity; 2022 Nov; 55(11):2074-2084.e5. PubMed ID: 36243008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Interferon Receptor IFNAR2 As a Novel HCV Entry Factor by Using Chemical Probes.
    Qing J; Wu M; Luo R; Chen J; Cao L; Zeng D; Shang L; Nong J; Wu Q; Ding BS; Chen X; Rao Z; Liu L; Lou Z
    ACS Chem Biol; 2020 May; 15(5):1232-1241. PubMed ID: 31972076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.